Computer-Based Cognitive Assessment and Web-Based Work Status Monitoring in Relapsing Multiple Sclerosis Patients Treated with Ozanimod

Brief description of study

The purpose of this research is to develop a registry of MS patients treated with Ozanimod that will track and relate measures of cognitive processing speed (i.e., how fast you can think) and executive functioning (i.e., higher level mental tasks) with work problems and job loss over two years.


Clinical Study Identifier: s23-00568
Principal Investigator: Mark Gudesblatt.
Other Investigator: Wendy M Doroski.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.